ArticleFrontiers in neurology2025
Development and validation of a blood biomarker-based model for differentiating stroke etiology in acute large vessel occlusion.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Diagnostic Yield of Comprehensive Etiologic Evaluation in Young Adults with Ischemic Stroke: Toward a Phenotype-Driven Approach.Journal of clinical medicine · 2026Article
- Blood Biomarkers for Large Vessel Occlusions: A Systematic Review.Stroke (Hoboken, N.J.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Early differentiation of stroke etiology in acute large vessel occlusion stroke (LVOS) is crucial for optimizing endovascular treatment strategies. This study aimed to develop and validate a prediction model for pre-procedural etiological differentiation based on admission laboratory parameters. Methods: We conducted a retrospective cohort study at a comprehensive stroke center, enrolling consecutive patients with acute LVOS who underwent endovascular treatment between January 2018 and October 2024. The study cohort ( Results: Of 415 enrolled patients, 199 (48.0%) had cardioembolism (CE). The final model incorporated six independent predictors: age [adjusted odds ratio (aOR) 1.03], male sex (aOR 0.35), white blood cell count (aOR 0.86), platelet-large cell ratio (aOR 1.06), aspartate aminotransferase (aOR 1.02), and non-high-density lipoprotein cholesterol (aOR 0.75). The model demonstrated good discriminatory ability in both the training set (AUC = 0.802) and the validation set (AUC = 0.784). Decision curve analysis demonstrated consistent clinical benefit across threshold probabilities of 20%-75%. Conclusion: We developed and internally validated a practical model using routine admission laboratory parameters to differentiate between CE and large artery atherosclerosis in acute LVOS. This readily implementable tool could aid in preoperative decision-making for endovascular intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.